FDA Cites Increases in IND Submissions and Anticipated Product Approvals that could benefit BioLife Solutions
New Guidance to Support Manufacturing Process Changes for Late-Phase Developers Without Necessarily Requiring New Clinical Trials
PR Newswire
BOTHELL, Wash., Jan. 22, 2019